A 38-year-old woman from rural Maharashtra presents for cervical cancer screening. Her Pap smear shows atypical squamous cells of undetermined significance (ASC-US). Regarding the management of ASC-US, all of the following are appropriate options EXCEPT:

## Management of ASC-US (Atypical Squamous Cells of Undetermined Significance) ### Clinical Context ASC-US is the most common abnormal Pap smear finding, occurring in 1–3% of screening populations. Management aims to identify underlying cervical intraepithelial neoplasia (CIN) while avoiding unnecessary colposcopy. ### Appropriate Management Strategies | Management Option | Rationale | Evidence | |---|---|---| | **Reflex HPV testing** | HPV-positive ASC-US has ~20% risk of CIN2+; HPV-negative has <5% risk. Reflex testing is most cost-effective. | ASCCP, NCCN guidelines | | **Repeat cytology at 12 months** | If repeat is normal, return to routine screening. If abnormal, colposcopy indicated. | Acceptable alternative when HPV testing unavailable | | **Immediate colposcopy** | Acceptable but less efficient; colposcopy referral rate ~30–40% for ASC-US. | Valid but not preferred first-line | **High-Yield:** The ASCCP algorithm for ASC-US: 1. **Reflex HPV testing** (preferred) 2. If HPV-positive → colposcopy 3. If HPV-negative → routine screening 4. If HPV unavailable → repeat Pap at 12 months ### Why HPV Vaccination Is NOT Appropriate for ASC-US **Key Point:** HPV vaccination is a **primary prevention strategy** for uninfected women, not a management tool for abnormal cytology. **Clinical Pearl:** A woman with ASC-US already has evidence of HPV exposure (or at least cytologic changes requiring investigation). Vaccination at this point: - Does not treat existing HPV infection - Does not prevent progression of current lesions - Delays necessary diagnostic evaluation (colposcopy/HPV testing) - May provide false reassurance, leading to loss to follow-up - Is not recommended by any major guideline (ASCCP, NCCN, WHO) for management of abnormal cytology **Warning:** Vaccination should NOT replace diagnostic workup. The woman requires immediate risk stratification via HPV testing or repeat cytology, not vaccination. ### Correct Answer HPV vaccination followed by routine screening in 3 years is **inappropriate** because: 1. It delays necessary diagnostic evaluation 2. Vaccination does not treat existing HPV infection or CIN 3. It is not supported by any guideline for ASC-US management 4. It may result in progression of undetected CIN2/3 to invasive cancer